Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects
Clinical trial NCT00297076 · TERMINATED
Trial details
- NCT number
- NCT00297076
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2007-10-01
- Enrollment
- 406
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.